SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-21-021327
Filing Date
2021-04-28
Accepted
2021-04-28 16:03:01
Documents
4
Period of Report
2021-06-03

Document Format Files

Seq Description Document Type Size
1 DEF 14A xene-def14a_20210603.htm DEF 14A 1718217
2 GRAPHIC g2vrdkey4gqr000001.jpg GRAPHIC 6067
3 GRAPHIC g2vrdkey4gqr000003.jpg GRAPHIC 1897
4 GRAPHIC g2vrdkey4gqr000002.jpg GRAPHIC 6067
  Complete submission text file 0001564590-21-021327.txt   1739009
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

IRS No.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36687 | Film No.: 21864155
SIC: 2834 Pharmaceutical Preparations